Search Results - "Wallemacq, P"

Refine Results
  1. 1

    Intra-cellular immunosuppressive drugs monitoring: A step forward towards better therapeutic efficacy after organ transplantation? by Capron, A., Haufroid, V., Wallemacq, P.

    Published in Pharmacological research (01-09-2016)
    “…[Display omitted] Immunosuppressive drugs (IS) used in solid organ transplantation are critical dose drugs with high intra- and inter-subject variability…”
    Get full text
    Journal Article
  2. 2

    The relationship between grip strength and muscle mass (MM), inflammatory biomarkers and physical performance in community-dwelling very old persons by Legrand, D, Adriaensen, W, Vaes, B, Matheï, C, Wallemacq, P, Degryse, J

    Published in Archives of gerontology and geriatrics (01-11-2013)
    “…Abstract The main consequence of the loss of MM and muscle strength is limitations of physical performance and disability in older people. It is unclear…”
    Get full text
    Journal Article
  3. 3

    CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study by Haufroid, V., Wallemacq, P., VanKerckhove, V., Elens, L., De Meyer, M., Eddour, D. C., Malaise, J., Lison, D., Mourad, M.

    Published in American journal of transplantation (01-11-2006)
    “…Genetic polymorphisms in biotransformation enzyme CYP3A5 (6986G > A, CYP3A5*3; 14690A > G, CYP3A5*6) and drug transporter ABCB1 (1236C > T; 2677G > T/A; 3435C…”
    Get full text
    Journal Article
  4. 4

    CHEMICAL RENAL DENERVATION WITH ALCOHOL – THE POST-MARKET STUDY MEDICATION ADHERENCE DATA by Persu, A, Toennes, S.W, Ritscher, S, Georges, C.M.G, Wallemacq, P, Haratani, N, Parise, H, Fischell, T, Lauder, L, Mahfoud, F

    Published in Journal of hypertension (01-07-2019)
    “…OBJECTIVE:In the European Peregrine post-market (PM) study, alcohol-mediated renal denervation (AMRDN) using the Peregrine Catheter was followed by a…”
    Get full text
    Journal Article
  5. 5

    Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice by LUBAMBA, B, LEBACQ, J, REYCHLER, G, MARBAIX, E, WALLEMACQ, P, LEBECQUE, P, LEAL, T

    Published in The European respiratory journal (2011)
    “…Sildenafil and vardenafil, two selective inhibitors of phosphodiesterase type 5 (PDE5) are able, when applied by intraperitoneal injection, to activate…”
    Get full text
    Journal Article
  6. 6

    The impact of the assay for measuring albumin on corrected (‘adjusted’) calcium concentrations by Labriola, Laura, Wallemacq, Pierre, Gulbis, Béatrice, Jadoul, Michel

    Published in Nephrology, dialysis, transplantation (01-06-2009)
    “…Background. The K/DOQI guidelines recommend the use of albumin-corrected calcium (Ca), phosphate, parathyroid hormone (PTH) and calcium-phosphate product as…”
    Get full text
    Journal Article
  7. 7

    Impact of Acute Infection Requiring Hospitalization on Tacrolimus Blood Levels in Kidney Transplant Recipients by Percy, C., Hassoun, Z., Mourad, M., De Meyer, M., Beguin, C., Jadoul, M., Goffin, E., Wallemacq, P., Kanaan, N.

    Published in Transplantation proceedings (01-11-2017)
    “…Tacrolimus is metabolized by members of the cytochrome p450 3A subfamily, and its bioavailability depends also on P-glycoprotein. We have observed that some…”
    Get full text
    Journal Article
  8. 8

    [OP.2B.07] ASSESSMENT OF DRUG ADHERENCE AND PSYCHOLOGICAL PROFILE IN PATIENTS WITH APPARENTLY TREATMENT-RESISTANT HYPERTENSION by Georges, C, Berra, E, Capron, A, Petit, G, De Timary, P, Wallemacq, P, Persu, A

    Published in Journal of hypertension (01-09-2017)
    “…OBJECTIVE:Recent studies using drug monitoring suggest that a high proportion of patients with apparently treatment-resistant hypertension (aTRH) are in fact…”
    Get full text
    Journal Article
  9. 9

    Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation by Guy-Viterbo, V., Scohy, A., Verbeeck, R. K., Reding, R., Wallemacq, P., Musuamba, Flora Tshinanu

    Published in European journal of clinical pharmacology (01-08-2013)
    “…Purposes Tacrolimus (TAC) is the most widely used immunosuppressant for the prevention of acute rejection after solid organ transplantation. Its…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    How appropriate is therapeutic drug monitoring for lithium? Data from the Belgian external quality assessment scheme by Delattre, I.K., Van de Walle, P., Van Campenhout, C., Neels, H., Verstraete, A.G., Wallemacq, P.

    Published in Clinical biochemistry (01-06-2015)
    “…Lithium remains a mainstay in the management of mood disorders. As with many psychotropic drugs, lithium treatment requires continuous observation for adverse…”
    Get full text
    Journal Article
  13. 13

    Cyclosporine A disposition, hepatic and renal tolerance in Wistar rat by Maerckx, C., Lombard, C. A., Tondreau, T., Najimi, M., Wallemacq, P., Sokal, E. M.

    Published in Immunopharmacology and immunotoxicology (01-12-2016)
    “…Cyclosporine A, a potent calcineurin inhibitor, has been widely used in organ transplantation and in the treatment of autoimmune diseases. It has, however,…”
    Get full text
    Journal Article
  14. 14

    Clinically unexpected cyclosporine levels using the ACMIA method on the RXL dimension analyser by MORELLE, Johann, WALLEMACQ, Pierre, VAN CAENEGHEM, Olivier, GOFFIN, Eric

    Published in Nephrology, dialysis, transplantation (01-04-2011)
    “…Safe use of cyclosporine (CsA) in solid organ transplantation relies on regular whole-blood drug monitoring. Several promising immmunoassays, e.g. the…”
    Get full text
    Journal Article
  15. 15

    Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance by BUYSSCHAERT, Martin, DRAMAIS, Anne-Sophie, WALLEMACQ, Pierre E, HERMANS, Michel P

    Published in Diabetes care (01-12-2000)
    “…Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. M Buysschaert , A S Dramais , P E Wallemacq and…”
    Get full text
    Journal Article
  16. 16

    Measuring the glomerular filtration rate in different age groups using iohexol, the protocol from the Belgian iohexol study by Van Pottelbergh, G., Hoste, L., Degryse, J., Pottel, H., Claes, K., Demoulin, N., Jadoul, M., Bammens, B., Wallemacq, P.

    Published in Clinical biochemistry (01-01-2013)
    “…Measuring the exact glomerular filtration rate (GFR) is difficult. Iohexol can be used instead of inulin or labeled EDTA or DTPA. In recent years, different…”
    Get full text
    Journal Article
  17. 17

    Formate kinetics in methanol poisoning by Hantson, P, Haufroid, V, Wallemacq, P

    Published in Human & experimental toxicology (01-02-2005)
    “…The objective is to describe the kinetics of formate, the main toxic metabolite of methanol, in a series of consecutive patients treated in the same intensive…”
    Get more information
    Journal Article
  18. 18

    Correlation of Mycophenolic Acid Pharmacokinetic Parameters with Side Effects in Kidney Transplant Patients Treated with Mycophenolate Mofetil by Mourad, Michel, Malaise, Jacques, Chaib Eddour, Djamila, De Meyer, Martine, Konig, Josiane, Schepers, Raf, Squifflet, Jean Paul, Wallemacq, Pierre

    Published in Clinical chemistry (Baltimore, Md.) (01-01-2001)
    “…Mycophenolate mofetil (MMF) is widely used in organ transplantation to prevent acute rejection. Because MMF can produce hematologic and/or gastrointestinal…”
    Get full text
    Journal Article
  19. 19
  20. 20